Patents by Inventor Jun Takeuchi

Jun Takeuchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11418056
    Abstract: A monitoring control system includes: at least one transmission monitoring control subsystem; and at least one distribution monitoring control subsystem. The transmission monitoring control subsystem and the distribution monitoring control subsystem respectively include an operation procedure creation unit that creates an operation procedure that defines a procedure of an operation for a facility installed in an electric power system, and an operation unit that, in a case an on-site operation that cannot be remotely performed on the facility is included in the operation procedure, transmits, to an on-site terminal associated with the on-site operation, a start confirmation instruction to confirm whether or not the on-site operation can be started and the operation procedure for the on-site operation. The monitoring control system performs monitoring control of the power transmission system and the power distribution system based on the operation procedure.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: August 16, 2022
    Assignees: Toshiba Energy Systems & Solutions Corporation, Tokyo Electric Power Company Holdings, Incorporated
    Inventors: Hiroaki Fujiura, Masami Onishi, Hirofumi Fujii, Hiroaki Sato, Koichi Takeuchi, Junya Yamamoto, Takashi Eguchi, Tomohiro Kubo, Masanori Endo, Kenji Kitami, Takaaki Hosaka, Jun Inoue
  • Publication number: 20220254814
    Abstract: An active matrix substrate includes first and second TFTs. The first TFT includes a first lower electrode, a first insulating layer, a first oxide semiconductor layer, and a first gate electrode. The first oxide semiconductor layer includes a first channel region overlapping the first gate electrode when viewed in a normal direction of the substrate. The first lower electrode has a first light-shielding portion overlapping the entire first channel region and including a first metal film. The second TFT includes a second lower electrode, the first insulating layer, a second oxide semiconductor layer, and a second gate electrode. The second oxide semiconductor layer includes a second channel region overlapping the second gate electrode when viewed in the normal direction. The second lower electrode has a light-transmitting portion overlapping the second channel region and including a first transparent conductive film but not a light-shielding metal film.
    Type: Application
    Filed: February 2, 2022
    Publication date: August 11, 2022
    Inventors: Jun NISHIMURA, Akira TAGAWA, Yohei TAKEUCHI, Yasuaki IWASE
  • Patent number: 11392864
    Abstract: An information processing system includes: a movable object that operates as a movable shop after business hours of a predetermined shop; and a control unit that executes acquiring product information, the product information being information relevant to a plurality of foodstuffs loaded in the movable object, each of the plurality of foodstuffs being a product of the predetermined shop and being discounted due to an expiration date, and controlling a route of the movable object based on the product information. The control unit controls the route of the movable object, based on a ratio of kinds of the plurality of foodstuffs loaded in the movable object, as the product information.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: July 19, 2022
    Assignee: TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventors: Zekai Qiu, Akie Sakiyama, Yusuke Takeuchi, Jun Hioki, Shinji Sassa, Hiromitsu Fujii, Keita Teruuchi
  • Patent number: 11162180
    Abstract: A hydrogen station includes a state management apparatus that is connected to each of a plurality of systems and manages the states of the plurality of systems, and a safety control apparatus that is formed separately from the main equipment and is connected to the state management apparatus. The state management apparatus performs first watchdog control to check operations of the plurality of systems and the safety control apparatus performs second watchdog control to check an operation of the state management apparatus. The state management apparatus or the safety control apparatus cuts off the power supply from the safety control apparatus to the main equipment if an abnormality is recognized by the second watchdog control, even if the first watchdog control indicates correct operation.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: November 2, 2021
    Assignee: HONDA MOTOR CO., LTD.
    Inventors: Shuichi Kazuno, Takeo Fukuda, Jun Takeuchi, Hisashi Nagaoka
  • Publication number: 20210261446
    Abstract: A water electrolysis system includes: a water electrolyzer configured to electrolyze water to generate gas including oxygen and hydrogen; a gas-liquid separator configured to separate gas phase including hydrogen from liquid phase of the gas generated by the water electrolyzer; a water level detector configured to detect a water level in the gas-liquid separator; a pressure detector configured to detect a pressure of the gas phase in the gas-liquid separator; and a CPU and a memory coupled to the CPU. The CPU is configured to perform: calculating an error of the water level in the gas-liquid separator detected by the water level detector based on the pressure of the gas phase in the gas-liquid separator detected by the pressure detector.
    Type: Application
    Filed: February 11, 2021
    Publication date: August 26, 2021
    Inventors: Yuji Asano, Jun Takeuchi, Kazuya Aoki
  • Publication number: 20200392110
    Abstract: A compound represented by general formula (I) has a strong Axl inhibitory activity by introducing a distinctive bicyclic structure in which a saturated carbon ring is fused to a pyridone ring, and can be a therapeutic agent for Axl-related diseases, for example, cancer such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, kidney diseases, immune system diseases, and circulatory system diseases
    Type: Application
    Filed: April 24, 2020
    Publication date: December 17, 2020
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Takayuki INUKAI, Jun TAKEUCHI, Tomoko YASUHIRO
  • Patent number: 10851493
    Abstract: A wire rope formed from a resin core and six strands, the resin core having an inner core with a circular cross section and an outer layer built up on the periphery thereof. The outer layer has a melting temperature lower than that of the inner core. The six strands are twisted together helically on the periphery of the resin core in an intertwining die in such a state that gaps are assured between the strands. The resulting wire rope is heated in a heating unit at a temperature higher than the melting temperature of the outer layer but lower than the melting temperature of the inner core. The wire rope is formed by subsequently compressing the six strands from the periphery thereof in a compressing die. The molten outer layer is hardened by natural cooling, after which the wire rope is taken up.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: December 1, 2020
    Assignee: TOKYO ROPE MANUFACTURING CO., LTD.
    Inventors: Shigeki Watanabe, Kaori Kanamori, Jun Takeuchi
  • Patent number: 10765676
    Abstract: The present invention provides a drug containing a compound having Trk-inhibiting activity as an active ingredient in prophylaxis and/or therapy for Trk-related diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease. A compound represented by the general formula (I), wherein all symbols represent the same meanings as described in the specification, a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof is useful as a drug component having Trk-inhibiting activity in prophylaxis and/or therapy of diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: September 8, 2020
    Assignee: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Jun Takeuchi, Satoshi Itadani, Kazuya Hashimura, Masahiro Ikura, Masato Higashino, Tetsuya Yasuhiro, Takeshi Nagaura
  • Patent number: 10767272
    Abstract: A water electrolysis system is equipped with a water electrolysis device, a water supply passage, a hydrogen supply passage, a gas-liquid separator, a first water drainage passage, a first water drainage valve, a second water drainage valve, a determination unit, and a valve control unit. In a method of stopping operation of the water electrolysis system, in a water drainage step, in the case that the determination unit determines that operation of the water electrolysis device has been stopped, the first water drainage valve is controlled to be placed in a valve open state, thereby draining liquid water from the gas-liquid separator into the first water drainage passage.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: September 8, 2020
    Assignee: HONDA MOTOR CO., LTD.
    Inventors: Jun Takeuchi, Daisuke Kurashina, Yukihiro Fukushima
  • Patent number: 10676462
    Abstract: A compound represented by general formula (I) has a strong Axl inhibitory activity by introducing a distinctive bicyclic structure in which a saturated carbon ring is fused to a pyridone ring, and can be a therapeutic agent for Axl-related diseases, for example, cancer such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, kidney diseases, immune system diseases, and circulatory system diseases
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: June 9, 2020
    Assignee: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Takayuki Inukai, Jun Takeuchi, Tomoko Yasuhiro
  • Patent number: 10648093
    Abstract: In a water electrolysis system and a method of controlling the water electrolysis system, a control device places a high pressure water discharge solenoid valve, a depressurizing solenoid valve, and a low pressure water discharge solenoid valve in the closed state. Further, a pressure acquisition unit obtains the electrolysis time pressure as a pressure in the low pressure water sealing container during production of hydrogen by a water electrolyzer. Further, the control device determines the occurrence of hydrogen leakage in a depressurizing line based on at least the electrolysis time pressure.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: May 12, 2020
    Assignee: HONDA MOTOR CO., LTD.
    Inventors: Daisuke Kurashina, Jun Takeuchi
  • Publication number: 20200010966
    Abstract: A hydrogen station includes a state management apparatus that is connected to each of a plurality of systems and manages the states of the plurality of systems, and a safety control apparatus that is formed separately from the main equipment and is connected to the state management apparatus. The state management apparatus performs first watchdog control to check operations of the plurality of systems and the safety control apparatus performs second watchdog control to check an operation of the state management apparatus. The state management apparatus or the safety control apparatus cuts off the power supply from the safety control apparatus to the main equipment if an abnormality is recognized by the second watchdog control, even if the first watchdog control indicates correct operation.
    Type: Application
    Filed: July 3, 2019
    Publication date: January 9, 2020
    Inventors: Shuichi Kazuno, Takeo Fukuda, Jun Takeuchi, Hisashi Nagaoka
  • Publication number: 20200002313
    Abstract: A compound represented by general formula (I) has a strong Axl inhibitory activity by introducing a distinctive bicyclic structure in which a saturated carbon ring is fused to a pyridone ring, and can be a therapeutic agent for Axl-related diseases, for example, cancer such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, kidney diseases, immune system diseases, and circulatory system diseases
    Type: Application
    Filed: August 14, 2019
    Publication date: January 2, 2020
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Takayuki INUKAI, Jun TAKEUCHI, Tomoko YASUHIRO
  • Patent number: 10501442
    Abstract: A compound represented by general formula (I) has a strong Axl inhibitory activity by introducing a distinctive bicyclic structure in which a saturated carbon ring is fused to a pyridone ring, and can be a therapeutic agent for Axl-related diseases, for example, cancer such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, kidney diseases, immune system diseases, and circulatory system diseases
    Type: Grant
    Filed: December 31, 2018
    Date of Patent: December 10, 2019
    Assignee: ONO PHARMACEUTICALS CO., LTD.
    Inventors: Takayuki Inukai, Jun Takeuchi, Tomoko Yasuhiro
  • Publication number: 20190313951
    Abstract: An organism analyzing apparatus includes an information acquiring section configured to acquire an amount of change in a blood glucose level due to ingestion of an organism and a sugar-content estimating section configured to estimate, according to the amount of change in the blood glucose level, sugar content ingested by the organism through the ingestion.
    Type: Application
    Filed: April 12, 2019
    Publication date: October 17, 2019
    Applicant: SEIKO EPSON CORPORATION
    Inventor: Jun TAKEUCHI
  • Patent number: 10399959
    Abstract: In order to provide a prophylactic and/or therapeutic agent for Trk-related diseases, the present invention provides a compound which has a selective Trk-inhibiting activity and persistently inhibits NGF vascular hyper permeability and does not have a drug interaction and in addition thereto, is excellent in solubility and absorbability against free bases. The compound of the present invention has a selective Trk-inhibiting activity and persistently inhibits NGF vascular hyper permeability and does not have a drug interaction and is excellent in solubility and absorbability against free bases, and is therefore useful as a prophylactic and/or therapeutic agent for Trk-related diseases.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: September 3, 2019
    Assignee: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Jun Takeuchi, Satoshi Itadani, Masahiro Ikura, Masato Higashino, Hideomi Kijima, Shizuka Ono, Tetsuya Yasuhiro, Takeshi Nagaura
  • Publication number: 20190231777
    Abstract: The present invention provides a drug containing a compound having Trk-inhibiting activity as an active ingredient in prophylaxis and/or therapy for Trk-related diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease. A compound represented by the general formula (I), wherein all symbols represent the same meanings as described in the specification, a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof is useful as a drug component having Trk-inhibiting activity in prophylaxis and/or therapy of diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease.
    Type: Application
    Filed: April 5, 2019
    Publication date: August 1, 2019
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Jun TAKEUCHI, Satoshi ITADANI, Kazuya HASHIMURA, Masahiro IKURA, Masato HIGASHINO, Tetsuya YASUHIRO, Takeshi NAGAURA
  • Publication number: 20190203412
    Abstract: A wire rope formed from a resin core and six strands, the resin core having an inner core with a circular cross section and an outer layer built up on the periphery thereof. The outer layer has a melting temperature lower than that of the inner core. The six strands are twisted together helically on the periphery of the resin core in an intertwining die in such a state that gaps are assured between the strands. The resulting wire rope is heated in a heating unit at a temperature higher than the melting temperature of the outer layer but lower than the melting temperature of the inner core. The wire rope is formed by subsequently compressing the six strands from the periphery thereof in a compressing die. The molten outer layer is hardened by natural cooling, after which the wire rope is taken up.
    Type: Application
    Filed: March 7, 2019
    Publication date: July 4, 2019
    Applicant: TOKYO ROPE MANUFACTURING CO., LTD.
    Inventors: Shigeki WATANABE, Kaori KANAMORI, Jun TAKEUCHI
  • Patent number: 10300060
    Abstract: The present invention provides a drug containing a compound having Trk-inhibiting activity as an active ingredient in prophylaxis and/or therapy for Trk-related diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease. A compound represented by the general formula (I), wherein all symbols represent the same meanings as described in the specification, a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof is useful as a drug component having Trk-inhibiting activity in prophylaxis and/or therapy of diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: May 28, 2019
    Assignee: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Jun Takeuchi, Satoshi Itadani, Kazuya Hashimura, Masahiro Ikura, Masato Higashino, Tetsuya Yasuhiro, Takeshi Nagaura
  • Patent number: D913608
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: March 16, 2021
    Assignee: NECOICHI CO., LTD.
    Inventor: Jun Takeuchi